The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about many questions as hospitals and blood centers prepare to order the testing. We've put together a FAQ document to clarify what we know today. We will update the document as we get more information on existing questions and as new questions get asked, and will update the blog with the revised FAQ document.
Thanks for your support as we work to rapidly get this testing available to you. You can find the FAQ document here: CTS COVID-19 Questions and Answers
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
Reminder: On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the ch...
On February 18, 2019, the new CTS Laboratory Information System was successfully implemented in Tamp...
Reminder test emails for the Health and Human Services (HHS) email notifications for WNV reactives h...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...